Statistics for Champions Oncology (id:5717 CSBR)

Valuation metrics

Market cap

61.17M

Enterprise value

65.39M

Trailing P/E (ttm)

-8.43

Forward P/E

23.68

PEG ratio

23.68

Price/Sales (ttm)

1.18

Price/Book (mrq)

-186.30

Enterprise Value/Revenue

1.27

Enterprise Value/EBITDA

-55.93

Overview

Shares outstanding

13.59M

Float

4.79M

Shares short

189.50K

% Held by insiders

0.26%

% Held by institutions

0.51%

Average volume (10 days)

8.52K

Average volume (90 days)

Price summary

52-Week low

3.60

52-Week high

7.13

52-Week change

-20.88%

Beta

0.49

50-Day moving average

4.46

200-Day moving average

4.88

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

August 12th, 2015

Financials

Fiscal year

Fiscal year ends

April 30th, 2024

Most recent quarter (mrq)

July 31th, 2024

Profitability

Profit margin

-6.58%

Operating margin

9.45%

Operational effectiveness

Return on assets

-6.93%

Return on equity

-432.46%

Income statement

Revenue (ttm)

3.81

Revenue per share (ttm)

3.81

Quarterly revenue growth (yoy)

Gross profit (ttm)

20.75M

EBITDA

-1,169,000.00

Net income to common (ttm)

-3,397,000.00

Diluted EPS (ttm)

-0.26

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

2.89M

Total cash per share (mrq)

0.21

Total debt (mrq)

7.11M

Total Debt/Equity (mrq)

-21.41

Current ratio (mrq)

68.80%

Book value per share (mrq)

-0.02

Cash flow

Cash flow statement

-1,835,000.00

Levered free cash flow (LFCF)

-837,500.00